If you've started researching GLP-1 medications, you've probably run into two confusing worlds: the insurance path, where prices vary wildly and most applications get denied, and the self-pay path, where the numbers are transparent but you shoulder the full cost. This guide breaks down what each route actually costs in 2026, why so many patients get denied, and which self-pay options beat insurance copays outright.
How insurance covers GLP-1 medications
Commercial insurance coverage for GLP-1s falls into three buckets. The first is full coverage, where the plan treats obesity as a chronic condition and covers medications like Wegovy or Zepbound with a standard copay after prior authorization. The second is diabetes-only coverage, where Ozempic and Mounjaro are covered for Type 2 diabetes but weight-loss branded versions are excluded. The third — and unfortunately the largest — is exclusion, where the plan document simply says anti-obesity medications are not a covered benefit.
Even in the "full coverage" bucket, patients face prior authorization requirements. Insurers typically demand a documented BMI of 30 or higher (or 27 with a comorbidity like hypertension, Type 2 diabetes, or sleep apnea), evidence of a prior 6-month lifestyle modification program, and sometimes step therapy — trying older, cheaper weight-loss drugs first. According to a 2025 analysis by the Kaiser Family Foundation, only about 30% of commercial plans cover GLP-1s for obesity, and among covered plans, roughly half of initial prior auth requests are denied on the first pass.
Why so many patients get denied
Denial is the rule, not the exception. The four most common denial reasons we see in 2026 are:
- Plan exclusion. The employer chose a plan design that excludes anti-obesity medication entirely. No appeal will fix this — it's not a medical decision, it's a benefit design.
- BMI threshold not met. Patients with a BMI of 25-29 without a qualifying comorbidity are rejected automatically.
- Documentation gap. No record of a supervised lifestyle program, no recent weight history, or missing labs.
- Formulary preference. The plan prefers a different GLP-1 (for example, covering Wegovy but not Zepbound, or vice versa).
Appeals work in roughly 40% of cases if you have strong documentation — recent labs, a diagnosed comorbidity, and a physician letter of medical necessity. But the process takes weeks, and many patients decide the insurance fight isn't worth it compared to paying cash for a compounded alternative.
Self-pay alternatives: the compounded route
Compounded semaglutide and tirzepatide have become the default for uninsured and underinsured patients. Licensed 503A compounding pharmacies produce the medication using FDA-approved active pharmaceutical ingredients, prescribed by a telehealth provider after a medical evaluation. The key advantages: no prior authorization, no step therapy, transparent monthly pricing, and you can start within a week of your first consult.
The caveat — and it's important — is that compounded medications are not FDA-evaluated as finished products. They're legal and widely used, but quality control depends on the pharmacy. We cover the legality and pharmacy vetting in depth in our compounded semaglutide legality guide.
Full cost breakdown — April 2026
| Scenario | Monthly Cost | Annual Cost | Notes |
|---|---|---|---|
| Wegovy — insurance, $25 copay | $25 | $300 | Best case, ~15% of patients |
| Wegovy — insurance, $100 copay | $100 | $1,200 | Typical covered plan |
| Zepbound — insurance, $75 copay | $75 | $900 | Requires prior auth |
| Compounded semaglutide (Eden) | $196 | $2,352 | Cash-pay, no insurance |
| Compounded semaglutide (Sprout) | $149 | $1,788 | Cash-pay, no insurance |
| Compounded tirzepatide (MyStart) | $249 | $2,988 | Cash-pay, no insurance |
| Wegovy — no insurance, retail | $1,349 | $16,188 | Novo Nordisk list price |
| Zepbound — no insurance, retail | $1,086 | $13,032 | Includes LillyDirect savings |
| Ozempic — off-label, cash | $968 | $11,616 | Rarely a good option |
Prices verified against provider websites and GoodRx in April 2026. Your actual copay depends on your specific plan's formulary tier and deductible status.
Which telehealth providers accept insurance
If you want to use insurance, a handful of telehealth services specialize in navigating prior authorization. Ro Body ($499/mo membership) has the highest success rate at getting Wegovy and Zepbound approved and handles all paperwork. Calibrate ($199/mo) bundles coaching with insurance coordination. Noom Med bills insurance where eligible and falls back to cash-pay compounded options otherwise. PlushCare takes most PPO plans for the visit itself, with the pharmacy billing insurance directly.
Cash-first providers — Eden, Sprout Health, and MyStart — do not bill insurance. Their pitch is simple: skip the prior auth fight, get a predictable monthly price, start this week. For patients whose insurance excludes GLP-1s outright, these are often the only practical options. See our full price comparison across 10+ providers.
Recommendation by situation
If your plan covers GLP-1s and you have BMI ≥ 30: Start with Ro Body or Calibrate. Let them handle prior auth. Expect 2-6 weeks to first shipment, but a $25-100 monthly copay makes it worth the wait.
If your plan excludes weight-loss medications: Don't waste time on appeals unless you have a diabetes or cardiovascular diagnosis. Go straight to a cash-pay compounded provider. Eden and Sprout are our top picks based on pricing and pharmacy vetting.
If you have BMI 27-29 with no comorbidity: Insurance denial is almost certain. Compounded self-pay at $149-$249/mo is your realistic path. Ask your prescriber about a lower starter dose to stretch the budget during titration.
If you have Type 2 diabetes: Insurance coverage for Ozempic or Mounjaro is far more likely. Ask your primary care doctor first before going telehealth — the copay path through your existing plan is usually cheapest.
See which provider fits your situation
Our 60-second quiz matches you with providers based on insurance status, budget, and whether you prefer brand-name or compounded medication.
Find My Match →Frequently asked questions
How much does GLP-1 cost with insurance in 2026?
If your plan covers weight-loss medications and you meet criteria, copays typically range from $25 to $100 per month. But roughly 70% of commercial plans either exclude weight-loss drugs or require strict prior authorization, so most patients don't hit those low copay numbers.
Why is my insurance denying Wegovy or Zepbound?
The most common denial reasons in 2026 are plan exclusion (employer opted out), BMI below the 30 or 27-with-comorbidity threshold, missing documentation of a prior 6-month lifestyle program, or step therapy requirements you haven't completed.
Is compounded semaglutide cheaper than insurance copays?
Often yes. Compounded semaglutide through telehealth runs $149-$299 per month all-in. If your insurance copay for Wegovy is $50/mo that's still cheaper, but when prior auth, step therapy, and coaching add-ons stack up, compounded self-pay can beat an insured path.
Which telehealth providers accept insurance for GLP-1?
Ro Body, Calibrate, Noom Med, and PlushCare all bill insurance for the medication in 2026. Calibrate and Ro handle prior authorization paperwork on your behalf.
Will Medicare cover Ozempic or Wegovy?
Medicare Part D covers Ozempic for Type 2 diabetes. As of March 2026, Medicare still does not cover Wegovy or Zepbound solely for obesity, though it now covers Wegovy when prescribed for cardiovascular risk reduction in patients with established heart disease.
Can I use HSA or FSA funds for compounded GLP-1?
Yes. Prescribed GLP-1 medications — including compounded semaglutide from a licensed pharmacy — are HSA and FSA eligible when prescribed for a diagnosed condition.
What happens if I lose insurance coverage mid-treatment?
Don't stop abruptly — weight rebound is well-documented. Most patients transitioning off insurance switch to compounded semaglutide through a cash-pay telehealth provider to maintain their titrated dose without interruption.
The bottom line
Insurance is the cheapest path — when it works. The reality in 2026 is that it works for a minority of patients. For everyone else, compounded semaglutide at $149-$299/mo has become the de facto standard. If you're shopping, our cheapest GLP-1 online guide and step-by-step telehealth guide walk you through the process in detail. Sources: FDA Drug Safety, Kaiser Family Foundation.